Blue fog: Citalopram, methylene blue, serotonin syndrome

Toby N. Weingarten; Wayne T. Nicholson; Juraj Sprung

doi:10.1007/978-1-4614-7495-1_175

Blue fog: Citalopram, methylene blue, serotonin syndrome

Toby N. Weingarten, Wayne T. Nicholson, Juraj Sprung

Anesthesiology

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

This case discusses a pharmacodynamics interaction between citalopram and methylene blue, resulting in serotonin syndrome. Citalopram is a selective serotonin reuptake inhibitor and methylene blue is a reversible monoamine oxidase inhibitor.

Original language	English (US)
Title of host publication	A Case Approach to Perioperative Drug-Drug Interactions
Publisher	Springer New York
Pages	779-783
Number of pages	5
ISBN (Print)	9781461474951, 9781461474944
DOIs	https://doi.org/10.1007/978-1-4614-7495-1_175
State	Published - Sep 15 2015

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1007/978-1-4614-7495-1_175

Cite this

@inbook{52315465177c4060bbefe2a7e377fc37,

title = "Blue fog: Citalopram, methylene blue, serotonin syndrome",

abstract = "This case discusses a pharmacodynamics interaction between citalopram and methylene blue, resulting in serotonin syndrome. Citalopram is a selective serotonin reuptake inhibitor and methylene blue is a reversible monoamine oxidase inhibitor.",

author = "Weingarten, {Toby N.} and Nicholson, {Wayne T.} and Juraj Sprung",

year = "2015",

month = sep,

day = "15",

doi = "10.1007/978-1-4614-7495-1_175",

language = "English (US)",

isbn = "9781461474951",

pages = "779--783",

booktitle = "A Case Approach to Perioperative Drug-Drug Interactions",

publisher = "Springer New York",

}

TY - CHAP

T1 - Blue fog

T2 - Citalopram, methylene blue, serotonin syndrome

AU - Weingarten, Toby N.

AU - Nicholson, Wayne T.

AU - Sprung, Juraj

PY - 2015/9/15

Y1 - 2015/9/15

N2 - This case discusses a pharmacodynamics interaction between citalopram and methylene blue, resulting in serotonin syndrome. Citalopram is a selective serotonin reuptake inhibitor and methylene blue is a reversible monoamine oxidase inhibitor.

AB - This case discusses a pharmacodynamics interaction between citalopram and methylene blue, resulting in serotonin syndrome. Citalopram is a selective serotonin reuptake inhibitor and methylene blue is a reversible monoamine oxidase inhibitor.

UR - http://www.scopus.com/inward/record.url?scp=84955355847&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955355847&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-7495-1_175

DO - 10.1007/978-1-4614-7495-1_175

M3 - Chapter

AN - SCOPUS:84955355847

SN - 9781461474951

SN - 9781461474944

SP - 779

EP - 783

BT - A Case Approach to Perioperative Drug-Drug Interactions

PB - Springer New York

ER -

Blue fog: Citalopram, methylene blue, serotonin syndrome

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this